APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hepatitis B Vaccines

Hepatitis B vaccine is a vaccine that prevents hepatitis B.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Hepatitis B vaccine is a vaccine that prevents hepatitis B.

Selected research

Industry Growth & Trends

Global Hepatitis B Vaccines Industry Growth and Trends Forecast to 2032

28 December 202595 pages

Choose your research edition.

Industry ResearchHepatitis B Vaccines Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Hepatitis B Vaccines Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Hepatitis B Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hepatitis B Vaccines Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Hepatitis B Vaccines Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

Hepatitis B vaccine is a vaccine that prevents hepatitis B.

In the last several years, Global market of Hepatitis B vaccine developed smoothly, with an average growth rate of -0.32%.

The classification of Hepatitis B vaccine includes Yeast Derived, CHO Derived, and the sales proportion of Yeast Derived in 2019 is about 97%. Hepatitis B vaccine is widely used for Children and Adult. About 84% of Hepatitis B vaccine is used for Children.

Read the full market overview

Asia-Pacific is the largest consumption place, with a consumption market share nearly 50% in 2019. Following Asia-Pacific, Middle East and Africa is the second largest consumption place with the consumption market share of nearly 30%.

Market competition is intense. GSK, NCPC, Merck, Bio Kangtai, Dynavax, Hissen, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers.

Report Scope

This report provides a structured, data-driven view of the global Hepatitis B Vaccines market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Hepatitis B Vaccines market size, estimates, and forecasts are presented in terms of sales volume (M Doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Hepatitis B Vaccines market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Hepatitis B Vaccines.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Hepatitis B Vaccines market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Hepatitis B Vaccines Market by Company

GSK

NCPC

Merck

Bio Kangtai

Dynavax

Hissen

KM Biologics

LG Life Sciences

Serum Institute

Hepatitis B Vaccines Segment by Type

Yeast Derived

CHO Derived

Hepatitis B Vaccines Segment by Application

Children

Adult

Hepatitis B Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hepatitis B Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hepatitis B Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hepatitis B Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hepatitis B Vaccines manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Hepatitis B Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Yeast Derived Table 2. Major Company of CHO Derived Table 3. Global Hepatitis B Vaccines Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses) Table 5. Global Hepatitis B Vaccines Sales Market Share in Volume by Type (2021-2026) Table 6. Global Hepatitis B Vaccines Sales by Type (2021-2026) & (US$ Million) Table 7. Global Hepatitis B Vaccines Sales Market Share in Value by Type (2021-2026) Table 8. Global Hepatitis B Vaccines Price by Type (2021-2026) & (USD/Doses) Table 9. Global Hepatitis B Vaccines Sales by Type (2027-2032) & (M Doses) Table 10. Global Hepatitis B Vaccines Sales Market Share in Volume by Type (2027-2032) Table 11. Global Hepatitis B Vaccines Sales by Type (2027-2032) & (US$ Million) Table 12. Global Hepatitis B Vaccines Sales Market Share in Value by Type (2027-2032) Table 13. Global Hepatitis B Vaccines Price by Type (2027-2032) & (USD/Doses) Table 14. North America Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses) Table 15. North America Hepatitis B Vaccines Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses) Table 17. Europe Hepatitis B Vaccines Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses) Table 19. Asia-Pacific Hepatitis B Vaccines Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses) Table 21. Latin America Hepatitis B Vaccines Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Hepatitis B Vaccines Sales by Type (2021-2026) & (M Doses) Table 23. Middle East and Africa Hepatitis B Vaccines Sales by Type (2021-2026) & (US$ Million) Table 24. Hepatitis B Vaccines Industry Trends Table 25. Hepatitis B Vaccines Industry Drivers Table 26. Hepatitis B Vaccines Industry Opportunities and Challenges Table 27. Hepatitis B Vaccines Industry Restraints Table 28. Global Hepatitis B Vaccines Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Hepatitis B Vaccines Revenue Market Share by Company (2021-2026) Table 30. Global Hepatitis B Vaccines Sales by Company (2021-2026) & (M Doses) Table 31. Global Hepatitis B Vaccines Sales Share by Company (2021-2026) Table 32. Global Hepatitis B Vaccines Market Price by Company (2021-2026) & (USD/Doses) Table 33. Global Hepatitis B Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Hepatitis B Vaccines Major Company Production Sites and Headquarters Table 35. Global Hepatitis B Vaccines Company, Product Type & Application Table 36. Global Hepatitis B Vaccines Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Hepatitis B Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Hepatitis B Vaccines Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Hepatitis B Vaccines Sales by Region (2021-2026) & (M Doses) Table 41. Global Hepatitis B Vaccines Sales Market Share in Volume by Region (2021-2026) Table 42. Global Hepatitis B Vaccines Sales by Region (2021-2026) & (US$ Million) Table 43. Global Hepatitis B Vaccines Sales Market Share in Value by Region (2021-2026) Table 44. Global Hepatitis B Vaccines Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 45. Global Hepatitis B Vaccines Sales by Region (2027-2032) & (M Doses) Table 46. Global Hepatitis B Vaccines Sales Market Share in Volume by Region (2027-2032) Table 47. Global Hepatitis B Vaccines Sales by Region (2027-2032) & (US$ Million) Table 48. Global Hepatitis B Vaccines Sales Market Share in Value by Region (2027-2032) Table 49. Global Hepatitis B Vaccines Sales (M Doses), Value (US$ Million), Price (USD/Doses) and Gross Margin (2027-2032) Table 50. Global Hepatitis B Vaccines Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses) Table 52. Global Hepatitis B Vaccines Sales Market Share in Volume by Application (2021-2026) Table 53. Global Hepatitis B Vaccines Sales by Application (2021-2026) & (US$ Million) Table 54. Global Hepatitis B Vaccines Sales Market Share in Value by Application (2021-2026) Table 55. Global Hepatitis B Vaccines Price by Application (2021-2026) & (USD/Doses) Table 56. Global Hepatitis B Vaccines Sales by Application (2027-2032) & (M Doses) Table 57. Global Hepatitis B Vaccines Sales Market Share in Volume by Application (2027-2032) Table 58. Global Hepatitis B Vaccines Sales by Application (2027-2032) & (US$ Million) Table 59. Global Hepatitis B Vaccines Sales Market Share in Value by Application (2027-2032) Table 60. Global Hepatitis B Vaccines Price by Application (2027-2032) & (USD/Doses) Table 61. North America Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses) Table 62. North America Hepatitis B Vaccines Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses) Table 64. Europe Hepatitis B Vaccines Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses) Table 66. Asia-Pacific Hepatitis B Vaccines Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses) Table 68. Latin America Hepatitis B Vaccines Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Hepatitis B Vaccines Sales by Application (2021-2026) & (M Doses) Table 70. Middle East and Africa Hepatitis B Vaccines Sales by Application (2021-2026) & (US$ Million) Table 71. GSK Company Information Table 72. GSK Business Overview Table 73. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 74. GSK Hepatitis B Vaccines Product Portfolio Table 75. GSK Recent Development Table 76. NCPC Company Information Table 77. NCPC Business Overview Table 78. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 79. NCPC Hepatitis B Vaccines Product Portfolio Table 80. NCPC Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 84. Merck Hepatitis B Vaccines Product Portfolio Table 85. Merck Recent Development Table 86. Bio Kangtai Company Information Table 87. Bio Kangtai Business Overview Table 88. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 89. Bio Kangtai Hepatitis B Vaccines Product Portfolio Table 90. Bio Kangtai Recent Development Table 91. Dynavax Company Information Table 92. Dynavax Business Overview Table 93. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 94. Dynavax Hepatitis B Vaccines Product Portfolio Table 95. Dynavax Recent Development Table 96. Hissen Company Information Table 97. Hissen Business Overview Table 98. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 99. Hissen Hepatitis B Vaccines Product Portfolio Table 100. Hissen Recent Development Table 101. KM Biologics Company Information Table 102. KM Biologics Business Overview Table 103. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 104. KM Biologics Hepatitis B Vaccines Product Portfolio Table 105. KM Biologics Recent Development Table 106. LG Life Sciences Company Information Table 107. LG Life Sciences Business Overview Table 108. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 109. LG Life Sciences Hepatitis B Vaccines Product Portfolio Table 110. LG Life Sciences Recent Development Table 111. Serum Institute Company Information Table 112. Serum Institute Business Overview Table 113. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2021-2026) Table 114. Serum Institute Hepatitis B Vaccines Product Portfolio Table 115. Serum Institute Recent Development Table 116. North America Hepatitis B Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 117. North America Hepatitis B Vaccines Sales by Country (2021-2026) & (M Doses) Table 118. North America Hepatitis B Vaccines Sales Market Share by Country (2021-2026) Table 119. North America Hepatitis B Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 120. North America Hepatitis B Vaccines Sales Market Share Forecast by Country (2027-2032) Table 121. North America Hepatitis B Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Hepatitis B Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Hepatitis B Vaccines Market Share by Country (2021-2026) Table 124. North America Hepatitis B Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Hepatitis B Vaccines Market Share Forecast by Country (2027-2032) Table 126. Europe Hepatitis B Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 127. Europe Hepatitis B Vaccines Sales by Country (2021-2026) & (M Doses) Table 128. Europe Hepatitis B Vaccines Sales Market Share by Country (2021-2026) Table 129. Europe Hepatitis B Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 130. Europe Hepatitis B Vaccines Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Hepatitis B Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Hepatitis B Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Hepatitis B Vaccines Market Share by Country (2021-2026) Table 134. Europe Hepatitis B Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Hepatitis B Vaccines Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Hepatitis B Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Hepatitis B Vaccines Sales by Country (2021-2026) & (M Doses) Table 138. Asia-Pacific Hepatitis B Vaccines Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Hepatitis B Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 140. Asia-Pacific Hepatitis B Vaccines Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Hepatitis B Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Hepatitis B Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Hepatitis B Vaccines Market Share by Country (2021-2026) Table 144. Asia-Pacific Hepatitis B Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Hepatitis B Vaccines Market Share Forecast by Country (2027-2032) Table 146. Latin America Hepatitis B Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 147. Latin America Hepatitis B Vaccines Sales by Country (2021-2026) & (M Doses) Table 148. Latin America Hepatitis B Vaccines Sales Market Share by Country (2021-2026) Table 149. Latin America Hepatitis B Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 150. Latin America Hepatitis B Vaccines Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Hepatitis B Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Hepatitis B Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Hepatitis B Vaccines Market Share by Country (2021-2026) Table 154. Latin America Hepatitis B Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Hepatitis B Vaccines Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Hepatitis B Vaccines Market Size Growth Rate (CAGR) by Country (M Doses): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Hepatitis B Vaccines Sales by Country (2021-2026) & (M Doses) Table 158. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Hepatitis B Vaccines Sales Forecast by Country (2027-2032) & (M Doses) Table 160. Middle East and Africa Hepatitis B Vaccines Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Hepatitis B Vaccines Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Hepatitis B Vaccines Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Hepatitis B Vaccines Market Share by Country (2021-2026) Table 164. Middle East and Africa Hepatitis B Vaccines Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Hepatitis B Vaccines Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Hepatitis B Vaccines Distributors List Table 169. Hepatitis B Vaccines Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Hepatitis B Vaccines Image Figure 2. Global Hepatitis B Vaccines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hepatitis B Vaccines Market Size (2021-2032) & (US$ Million) Figure 4. Global Hepatitis B Vaccines Sales (2021-2032) & (M Doses) Figure 5. Yeast Derived Image Figure 6. Global Yeast Derived Sales YoY Growth (2021-2032) & (M Doses) Figure 7. CHO Derived Image Figure 8. Global CHO Derived Sales YoY Growth (2021-2032) & (M Doses) Figure 9. Global Hepatitis B Vaccines Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Hepatitis B Vaccines Market Share by Type 2025 VS 2032 Figure 11. North America Hepatitis B Vaccines Sales Market Share in Volume by Type in 2025 Figure 12. North America Hepatitis B Vaccines Sales Market Share in Value by Type in 2025 Figure 13. Europe Hepatitis B Vaccines Sales Market Share in Volume by Type in 2025 Figure 14. Europe Hepatitis B Vaccines Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Hepatitis B Vaccines Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Hepatitis B Vaccines Sales Market Share in Value by Type in 2025 Figure 17. Latin America Hepatitis B Vaccines Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Hepatitis B Vaccines Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Hepatitis B Vaccines Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Hepatitis B Vaccines Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Hepatitis B Vaccines Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Children Image Figure 24. Global Children Sales YoY Growth (2021-2032) & (M Doses) Figure 25. Adult Image Figure 26. Global Adult Sales YoY Growth (2021-2032) & (M Doses) Figure 27. Global Hepatitis B Vaccines Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Hepatitis B Vaccines Market Share by Application 2025 VS 2032 Figure 29. North America Hepatitis B Vaccines Sales Market Share in Volume by Application in 2025 Figure 30. North America Hepatitis B Vaccines Sales Market Share in Value by Application in 2025 Figure 31. Europe Hepatitis B Vaccines Sales Market Share in Volume by Application in 2025 Figure 32. Europe Hepatitis B Vaccines Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Hepatitis B Vaccines Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Hepatitis B Vaccines Sales Market Share in Value by Application in 2025 Figure 35. Latin America Hepatitis B Vaccines Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Hepatitis B Vaccines Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Hepatitis B Vaccines Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Hepatitis B Vaccines Sales Market Share in Value by Application in 2025 Figure 39. North America Hepatitis B Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 40. North America Hepatitis B Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Hepatitis B Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Hepatitis B Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Hepatitis B Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 44. Europe Hepatitis B Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Hepatitis B Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Hepatitis B Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Hepatitis B Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 48. Asia-Pacific Hepatitis B Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Hepatitis B Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Hepatitis B Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Hepatitis B Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 52. Latin America Hepatitis B Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Hepatitis B Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Hepatitis B Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Hepatitis B Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Figure 56. Middle East and Africa Hepatitis B Vaccines Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Hepatitis B Vaccines Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Hepatitis B Vaccines Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Hepatitis B Vaccines Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Hepatitis B Vaccines Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Yeast Derived
  • CHO Derived
Applications
  • Children
  • Adult
Companies covered
  • GSK
  • NCPC
  • Merck
  • Bio Kangtai
  • Dynavax
  • Hissen
  • KM Biologics
  • LG Life Sciences
  • Serum Institute

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Hepatitis B Vaccines Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Hepatitis B Vaccines Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Hepatitis B Vaccines Market by Type
  6. 1.3.1 Yeast Derived
  7. 1.3.2 CHO Derived
  8. 1.4 Global Hepatitis B Vaccines Market Size by Type
  9. 1.4.1 Global Hepatitis B Vaccines Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Hepatitis B Vaccines Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Hepatitis B Vaccines Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Hepatitis B Vaccines Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Hepatitis B Vaccines Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Hepatitis B Vaccines Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Hepatitis B Vaccines Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Hepatitis B Vaccines Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Hepatitis B Vaccines Industry Trends
  2. 2.2 Hepatitis B Vaccines Industry Drivers
  3. 2.3 Hepatitis B Vaccines Industry Opportunities and Challenges
  4. 2.4 Hepatitis B Vaccines Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Hepatitis B Vaccines Revenue (2021-2026)
  2. 3.2 Global Top Players by Hepatitis B Vaccines Sales (2021-2026)
  3. 3.3 Global Top Players by Hepatitis B Vaccines Price (2021-2026)
  4. 3.4 Global Hepatitis B Vaccines Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hepatitis B Vaccines Major Company Production Sites & Headquarters
  6. 3.6 Global Hepatitis B Vaccines Company, Product Type & Application
  7. 3.7 Global Hepatitis B Vaccines Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hepatitis B Vaccines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hepatitis B Vaccines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hepatitis B Vaccines Tier 1, Tier 2, and Tier 3
4 Hepatitis B Vaccines Regional Status and Outlook
  1. 4.1 Global Hepatitis B Vaccines Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Hepatitis B Vaccines Historic Market Size by Region
  3. 4.2.1 Global Hepatitis B Vaccines Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Hepatitis B Vaccines Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Hepatitis B Vaccines Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Hepatitis B Vaccines Forecasted Market Size by Region
  7. 4.3.1 Global Hepatitis B Vaccines Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Hepatitis B Vaccines Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Hepatitis B Vaccines Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Hepatitis B Vaccines by Application
  1. 5.1 Hepatitis B Vaccines Market by Application
  2. 5.1.1 Children
  3. 5.1.2 Adult
  4. 5.2 Global Hepatitis B Vaccines Market Size by Application
  5. 5.2.1 Global Hepatitis B Vaccines Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Hepatitis B Vaccines Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Hepatitis B Vaccines Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Hepatitis B Vaccines Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Hepatitis B Vaccines Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Hepatitis B Vaccines Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Hepatitis B Vaccines Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Hepatitis B Vaccines Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 GSK
  2. 6.1.1 GSK Company Information
  3. 6.1.2 GSK Business Overview
  4. 6.1.3 GSK Hepatitis B Vaccines Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 GSK Hepatitis B Vaccines Product Portfolio
  6. 6.1.5 GSK Recent Developments
  7. 6.2 NCPC
  8. 6.2.1 NCPC Company Information
  9. 6.2.2 NCPC Business Overview
  10. 6.2.3 NCPC Hepatitis B Vaccines Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 NCPC Hepatitis B Vaccines Product Portfolio
  12. 6.2.5 NCPC Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Hepatitis B Vaccines Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Hepatitis B Vaccines Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Bio Kangtai
  20. 6.4.1 Bio Kangtai Company Information
  21. 6.4.2 Bio Kangtai Business Overview
  22. 6.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bio Kangtai Hepatitis B Vaccines Product Portfolio
  24. 6.4.5 Bio Kangtai Recent Developments
  25. 6.5 Dynavax
  26. 6.5.1 Dynavax Company Information
  27. 6.5.2 Dynavax Business Overview
  28. 6.5.3 Dynavax Hepatitis B Vaccines Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Dynavax Hepatitis B Vaccines Product Portfolio
  30. 6.5.5 Dynavax Recent Developments
  31. 6.6 Hissen
  32. 6.6.1 Hissen Company Information
  33. 6.6.2 Hissen Business Overview
  34. 6.6.3 Hissen Hepatitis B Vaccines Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hissen Hepatitis B Vaccines Product Portfolio
  36. 6.6.5 Hissen Recent Developments
  37. 6.7 KM Biologics
  38. 6.7.1 KM Biologics Company Information
  39. 6.7.2 KM Biologics Business Overview
  40. 6.7.3 KM Biologics Hepatitis B Vaccines Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 KM Biologics Hepatitis B Vaccines Product Portfolio
  42. 6.7.5 KM Biologics Recent Developments
  43. 6.8 LG Life Sciences
  44. 6.8.1 LG Life Sciences Company Information
  45. 6.8.2 LG Life Sciences Business Overview
  46. 6.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 LG Life Sciences Hepatitis B Vaccines Product Portfolio
  48. 6.8.5 LG Life Sciences Recent Developments
  49. 6.9 Serum Institute
  50. 6.9.1 Serum Institute Company Information
  51. 6.9.2 Serum Institute Business Overview
  52. 6.9.3 Serum Institute Hepatitis B Vaccines Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Serum Institute Hepatitis B Vaccines Product Portfolio
  54. 6.9.5 Serum Institute Recent Developments
7 North America by Country
  1. 7.1 North America Hepatitis B Vaccines Sales by Country
  2. 7.1.1 North America Hepatitis B Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Hepatitis B Vaccines Sales by Country (2021-2026)
  4. 7.1.3 North America Hepatitis B Vaccines Sales Forecast by Country (2027-2032)
  5. 7.2 North America Hepatitis B Vaccines Market Size by Country
  6. 7.2.1 North America Hepatitis B Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Hepatitis B Vaccines Market Size by Country (2021-2026)
  8. 7.2.3 North America Hepatitis B Vaccines Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Hepatitis B Vaccines Sales by Country
  2. 8.1.1 Europe Hepatitis B Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Hepatitis B Vaccines Sales by Country (2021-2026)
  4. 8.1.3 Europe Hepatitis B Vaccines Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Hepatitis B Vaccines Market Size by Country
  6. 8.2.1 Europe Hepatitis B Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Hepatitis B Vaccines Market Size by Country (2021-2026)
  8. 8.2.3 Europe Hepatitis B Vaccines Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Hepatitis B Vaccines Sales by Country
  2. 9.1.1 Asia-Pacific Hepatitis B Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Hepatitis B Vaccines Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Hepatitis B Vaccines Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Hepatitis B Vaccines Market Size by Country
  6. 9.2.1 Asia-Pacific Hepatitis B Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Hepatitis B Vaccines Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Hepatitis B Vaccines Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Hepatitis B Vaccines Sales by Country
  2. 10.1.1 South America Hepatitis B Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Hepatitis B Vaccines Sales by Country (2021-2026)
  4. 10.1.3 South America Hepatitis B Vaccines Sales Forecast by Country (2027-2032)
  5. 10.2 South America Hepatitis B Vaccines Market Size by Country
  6. 10.2.1 South America Hepatitis B Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Hepatitis B Vaccines Market Size by Country (2021-2026)
  8. 10.2.3 South America Hepatitis B Vaccines Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Hepatitis B Vaccines Sales by Country
  2. 11.1.1 Middle East and Africa Hepatitis B Vaccines Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Hepatitis B Vaccines Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Hepatitis B Vaccines Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Hepatitis B Vaccines Market Size by Country
  6. 11.2.1 Middle East and Africa Hepatitis B Vaccines Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Hepatitis B Vaccines Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Hepatitis B Vaccines Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Hepatitis B Vaccines Value Chain Analysis
  2. 12.1.1 Hepatitis B Vaccines Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Hepatitis B Vaccines Production Mode & Process
  7. 12.2 Hepatitis B Vaccines Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Hepatitis B Vaccines Distributors
  10. 12.2.3 Hepatitis B Vaccines Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst